Status Report
Currently all 50 states and the District of Columbia have one or more public health laboratories qualified to conduct confirmatory testing of the novel H1N1 virus. As a result, delivery of test results has been expedited, leading to improved disease control measures.
As of March 2010, the majority of influenza viruses identified continue to be 2009 H1N1 influenza A viruses. With rare exception, these viruses remain susceptible to the antiviral drugs oseltamivir and zanamivir.
Nationally, visits to doctors for influenza-like illness (ILI) remain relatively low. Laboratory-confirmed hospitalization rates have leveled off. No states reported widespread influenza activity between March 21-27, though regional flu activity has been reported in the Southeast US in recent weeks.
For immediate weekly updates on the status of the Flu in your region see CDC's FluView.
for public health laboratories (requires login)